Medesis Pharma SA operates as a clinical development stage biopharmaceutical company, which engages in the research and development of orally administered molecule drugs. The company was founded by Jean-Claude Maurel on April 3, 2004, and is headquartered in Baillargues, France.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company